CL2021002202A1 - Preparaciones para la prevención de enfermedades adquiridas a través de la cavidad oral y la faringe - Google Patents

Preparaciones para la prevención de enfermedades adquiridas a través de la cavidad oral y la faringe

Info

Publication number
CL2021002202A1
CL2021002202A1 CL2021002202A CL2021002202A CL2021002202A1 CL 2021002202 A1 CL2021002202 A1 CL 2021002202A1 CL 2021002202 A CL2021002202 A CL 2021002202A CL 2021002202 A CL2021002202 A CL 2021002202A CL 2021002202 A1 CL2021002202 A1 CL 2021002202A1
Authority
CL
Chile
Prior art keywords
ingredients
dentifrices
acquisition
prevent
pharynx
Prior art date
Application number
CL2021002202A
Other languages
English (en)
Inventor
Joseph G Montes
James Intrater
Original Assignee
Intramont Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/353,802 external-priority patent/US11517523B2/en
Application filed by Intramont Tech Inc filed Critical Intramont Tech Inc
Publication of CL2021002202A1 publication Critical patent/CL2021002202A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención incluye un dentífrico u otro producto aplicado por vía oral para su uso al menos una vez al día para ayudar a prevenir o inhibir la adquisición de un número de infecciones por los tejidos orales o faríngeos, que incluye particularmente el resfriado "común". Estas composiciones poseen una combinación de ingredientes que no se encuentra en otros dentífricos u otros productos aplicados por vía oral, y estos ingredientes funcionan juntos para interferir sinérgicamente con la adquisición de un número de patógenos. Los dentífricos tendrán los ingredientes dentífricos habituales conocidos para prevenir la caries dental, así como los que reducen la halitosis (es decir, el mal aliento) y previenen la gingivitis. Además, los dentífricos incluirán uno o más de: 1) el GALALCOOL® como un compuesto individual, y no como un componente de extracto; 2) la protoporfirina IX de zinc; y 3) uno o más taninos incoloros o de bajo color adicionales, cada uno como un compuesto individual y no como un componente de extracto.
CL2021002202A 2019-03-14 2021-08-18 Preparaciones para la prevención de enfermedades adquiridas a través de la cavidad oral y la faringe CL2021002202A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/353,802 US11517523B2 (en) 2017-09-12 2019-03-14 Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx

Publications (1)

Publication Number Publication Date
CL2021002202A1 true CL2021002202A1 (es) 2022-06-10

Family

ID=72426456

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021002202A CL2021002202A1 (es) 2019-03-14 2021-08-18 Preparaciones para la prevención de enfermedades adquiridas a través de la cavidad oral y la faringe

Country Status (13)

Country Link
EP (1) EP3937879B1 (es)
JP (2) JP7519364B2 (es)
CN (1) CN113453664A (es)
AU (2) AU2020235666B2 (es)
BR (1) BR112021016277A2 (es)
CA (1) CA3128127A1 (es)
CL (1) CL2021002202A1 (es)
DO (1) DOP2021000171A (es)
EA (1) EA202191829A1 (es)
IL (1) IL286256B2 (es)
MX (1) MX2021009928A (es)
PH (1) PH12021552180A1 (es)
WO (1) WO2020186258A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210338708A1 (en) * 2020-03-19 2021-11-04 Renibus Therapeutics, Inc. Method for treatment of coronavirus infection
CN111759851B (zh) * 2020-08-17 2021-01-26 广东盛普生命科技有限公司 单宁酸在制备抗冠状病毒的药物方面的应用
CN112402450A (zh) * 2020-11-26 2021-02-26 江苏泰德医药有限公司 一种防治新冠病毒的产品及制备方法
US20230149493A1 (en) * 2021-06-08 2023-05-18 Yuva Biosciences, Inc. Compositions and methods for treating covid-19 and symptoms thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB189324273A (en) * 1893-12-16 1895-02-02 Otto Christian Hagemann Improvements in the Extraction and Purification of Tannin.
JPS53148542A (en) * 1977-05-27 1978-12-25 Reiichi Yamaga Pharmaceutical composition densistry
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
JP3570482B2 (ja) * 1997-12-02 2004-09-29 ライオン株式会社 歯磨組成物及び苦味抑制方法
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
US20070092552A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Chewable lozenge cold remedy composition and method for making same
US20060141072A1 (en) * 2004-12-29 2006-06-29 Arvanitidou Evangelia S Oxidation resistant dentifrice compositions
US8900557B2 (en) * 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
CA2858372A1 (en) * 2011-11-10 2013-05-16 Lankenau Institute For Medical Research Compositions and methods for the prevention of microbial infections
US20150224202A1 (en) * 2014-02-03 2015-08-13 The Board Of Trustees Of The Leland Stanford Junior University Formulations and uses for microparticle delivery of zinc protoporphyrins
WO2015178791A1 (ru) * 2014-05-23 2015-11-26 Артур Викторович МАРТЫНОВ Косметологическая и фармацевтическая композиция
WO2016067283A1 (en) * 2014-10-30 2016-05-06 Rice Howard Virucidal compositions comprising tannins for nasal and pulmonary administration
ITUB20153821A1 (it) * 2015-09-23 2017-03-23 Agrocube S A Composizione biostimolante a base di tannini e/o loro derivati, pr il trattamento di vegetali coltivati e/o di loro parti
US20190076335A1 (en) * 2017-09-12 2019-03-14 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
US11517523B2 (en) * 2017-09-12 2022-12-06 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
CN108220031A (zh) * 2018-02-26 2018-06-29 酒泉市祁连天脉养生果酒有限公司 高品质陈酿型黑枸杞葡萄酒及其制备方法

Also Published As

Publication number Publication date
WO2020186258A1 (en) 2020-09-17
MX2021009928A (es) 2021-09-21
JP7519364B2 (ja) 2024-07-19
BR112021016277A2 (pt) 2021-10-13
EA202191829A1 (ru) 2021-12-21
EP3937879B1 (en) 2026-04-29
EP3937879C0 (en) 2026-04-29
AU2024219419A1 (en) 2024-09-26
IL286256B1 (en) 2025-10-01
AU2020235666B2 (en) 2024-06-06
IL286256B2 (en) 2026-02-01
IL286256A (en) 2021-10-31
CN113453664A (zh) 2021-09-28
AU2020235666A1 (en) 2021-08-26
PH12021552180A1 (en) 2022-08-31
EP3937879A4 (en) 2022-12-14
JP2022524486A (ja) 2022-05-06
EP3937879A1 (en) 2022-01-19
CA3128127A1 (en) 2020-09-17
DOP2021000171A (es) 2021-10-15
JP7893839B2 (ja) 2026-07-22
JP2024144432A (ja) 2024-10-11

Similar Documents

Publication Publication Date Title
DOP2021000171A (es) Preparaciones para la prevención de enfermedades adquiridas a través de la cavidad oral y faringe.
ES2795356T3 (es) Preparación de colutorios mejorados
NZ198348A (en) Mouthwashes containing zinc salts and hexetidine
MY148458A (en) Oral compositions containing extracts of rosmarinus and related methods
RU2017130866A (ru) Композиции для ухода за полостью рта и способы их применения
RU2017128410A (ru) Композиции для ухода за полостью рта и способы их применения
Ernst et al. Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control
PE20000650A1 (es) Composiciones orales mejoradas para el control y prevencion del sarro dental, mal olor oral, placa y gingivitis
BR112022007198A2 (pt) Composição de cuidado bucal
CL2020000629A1 (es) Composición dentrífica u otra preparación oral que comprende un almidón impregnado con sal de zinc y corilagina, para la prevención de enfermedades de la cavidad oral y faringe.
JP5205618B2 (ja) 抗菌剤
US20060140876A1 (en) Buccal cavity treatment composition and corresponding uses thereof
US20100297037A1 (en) Material composition for oral hygiene product
ES2884748T3 (es) Enjuague bucal a base de clorhexidina que previene las manchas de dientes
Shalini et al. Comparison of anti-plaque efficacy of green tea, herbal, and chlorhexidine mouthrinse in patients undergoing orthodontic treatment
Jameel et al. Is synthetic mouthwash the final choice to treat oral malodour?
JP2005179188A (ja) 歯垢染色剤
Biria et al. Evaluation of Antiplaque Efficacy of a Propolis-Based Herbal Toothpaste: A Single-Blind Parallel Clinical Trail
KR20160061852A (ko) 금속이온 봉쇄제와 이소프로필메틸페놀을 함유하는 구강 조성물
KR20170051006A (ko) 이소프로필메틸페놀과 구강조직수렴제를 함유하는 구강 조성물
US20260090966A1 (en) Urolithin compositions
Soesanto et al. Is herbal mouthwash as effective as chlorhexidine?: A review
WO2014193251A1 (en) Preparation for maintenance of oral cavity hygiene and prevention of plaque formation
Tonetto et al. Effectiveness of Oral Antiseptics on Tooth Biofilm: A Study in vivo
Al-Huwaizi et al. The Effect of Chlorhexidine Tooth Paste on the Tooth Shade (A Comparative Study)